Jonathan E. Rosenberg

Jonathan E. Rosenberg, MD

Genitourinary Medical Oncologist

Areas of Expertise

Conditions I Treat

  • Bladder cancer
  • Urethral and penile cancers and conditions

My Specialties

  • Clinical trials
  • Targeted therapy
  • Immunotherapy
View all expertise
Dr. Rosenberg's Office Information
Languages: English
Request an Appointment
Our Care Advisors can answer many of your questions. They will connect you with the best healthcare provider for your needs.
Back to top
English
Share

Get to Know Me

I am a medical oncologist who cares for people with genitourinary cancers. I have extensive experience treating urothelial cancers, which start in the bladder, ureters, renal pelvis, or urethra.

Read more
This provider is part of a team that was ranked #1 in the nation for Urology Cancer Care this year by U.S. News & World Report.

My interest in cancer was sparked as I watched my grandfather live with and ultimately pass away from prostate cancer. I witnessed firsthand the limited treatment options available for this disease in the 1980s. His experience inspired me to pursue a career in cancer research and treatment to improve outcomes for people with genitourinary cancers.

My goal is to tailor treatment according to each person’s needs and circumstances. I work as part of a team of cancer experts. We focus on all aspects of oncology to provide complete care for people with these diseases.

A urothelial cancer diagnosis can lead to understandable fear and confusion. When patients see me for the first time, they express concern about the extent of their illness, the available treatment options, and their prognosis. Educating patients to help them make informed decisions about their care is an important part of my job. I hope that people leave a visit with me with a better understanding of their condition and treatment options.

My research centers on developing treatment approaches and improving care for people with bladder cancer. My work includes understanding the genetic changes that lead to this cancer’s aggressiveness. I use those insights to develop new therapies. I also have a research interest in identifying useful predictive biomarkers. These tests help doctors pick treatments that may be more likely to work for a particular individual. I lead or participate in several studies that are testing these biomarkers.

I study new treatments that target cellular processes that fuel the growth and progression of bladder cancer and test new ways to harness the immune system to fight urothelial cancer. I lead multiple clinical trials evaluating targeted therapy, chemotherapy, and immunotherapy, either alone or in various combinations. I have been a leader in the development of immunotherapy for people with urothelial cancer that has spread and led the clinical trial that resulted in the first new drug approval by the US Food and Drug Administration for urothelial cancer in more than 20 years. I was also principal investigator of another trial that led to the FDA’s Breakthrough Therapy Designation for a new drug for this disease.

I became Chief of MSK’s Genitourinary Oncology Service in 2018. Before that, I was the Section Head for non-prostate genitourinary cancers at MSK. Prior to arriving at MSK in 2012, I was Clinical Director of the Genitourinary Oncology Center and Director of the Bladder Cancer Center at the Dana-Farber/Brigham and Women’s Cancer Center of Harvard Medical School.

I serve on several national committees dedicated to improving treatment for people with genitourinary cancers. I travel widely to speak about bladder cancer and immunotherapy, and I have presented my research at many national and international meetings.

What I Do at MSK

I'm a genitourinary (GU) medical oncologist, which is a cancer doctor who specializes in genitourinary (jeh-nih-toh-YOOR-ih-nayr-ee) cancers. This includes bladder, kidney, penis, prostate, and testicular cancers.

  • Chief, Genitourinary Oncology Service, Division of Solid Tumor Oncology
  • Enno W. Ercklentz, Jr. Chair
Areas of Expertise

Conditions I Treat

  • Bladder cancer
  • Urethral and penile cancers and conditions

My Specialties

  • Clinical trials
  • Targeted therapy
  • Immunotherapy
  • Combination therapy
  • Biomarker testing
Education & Honors

Education

  • MD, Harvard Medical School

Residencies

  • Internal Medicine - NewYork-Presbyterian/Weill Cornell Medical Center

Fellowships

  • Medical Oncology - University of California San Francisco Medical Center

Board Certifications

  • Medical Oncology

Awards and Honors

  • Castle Connolly: America’s Top Doctor (2025)
  • Castle Connolly: America’s Top Doctor (2024)
  • Top Doctors New York Metro Area, Castle Connolly (2023)
  • Castle Connolly: America's Top Doctors (2023)

Insurance Information

Understanding your insurance options is an important part of managing your cancer care. We have relationships with many common healthcare providers and plans.

Don't see your carrier or plan? We can help you understand your coverage.

If you don't have health insurance or are worried that your care may not be fully covered, our financial assistance programs may be able to help.

If you have questions about insurance, call us at 646-497-9176.

Make an Appointment

Women talking
New Patients
Scheduling an appointment is easy. Click or call 646-497-9068— we’re available 24 hours a day, 7 days a week
Make an Appointment
Current Patients
Request an appointment by logging in to MSK MyChart or calling your Care Team. If you are not enrolled in MSK MyChart, ask your Care Team to send you an invitation. You can also go to MSK MyChart and select “Sign up now.”

Contact and Location

Dr. Rosenberg sees patients at one location.

Office Phone
Location
New York, NY
Sidney Kimmel Center for Prostate and Urologic Cancers
353 East 68th Street New York NY 10065
Get Directions

Looking to see a doctor at a different location? See all MSK locations.

Colleagues

Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.

See all Genitourinary Oncology Service doctors

Clinical Trials

Read more
Smiling doctors in the lab
Find a Clinical Trial for You

Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.

You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.

Search clinical trials

Research and Publications

Publications on PubMed

Visit PubMed for a full listing of Dr. Rosenberg’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.

See all on PubMed

Disclosures

Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.

MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.

Jonathan E. Rosenberg discloses the following relationships and financial interests:

  • Abingworth LLP
    Professional Services and Activities
  • Aktis Oncology, Inc.
    Professional Services and Activities
  • Astellas
    Professional Services and Activities
  • AstraZeneca
    Professional Services and Activities
  • Bayer
    Professional Services and Activities
  • Boehringer Ingelheim
    Professional Services and Activities
  • Bristol-Myers Squibb
    Professional Services and Activities
  • CCO
    Professional Services and Activities
  • Century Therapeutics
    Professional Services and Activities
  • KaliVir Immunotherapeutics, Inc.
    Professional Services and Activities (Uncompensated)
  • Lilly Oncology
    Professional Services and Activities
  • Mashup Media, LLC
    Professional Services and Activities
  • Medical Educator Consortium, Inc.
    Professional Services and Activities (Uncompensated)
  • Medscape
    Professional Services and Activities
  • MJH Life Sciences
    Professional Services and Activities
  • PSL Group
    Professional Services and Activities
  • Research to Practice
    Professional Services and Activities
  • Seagen
    Professional Services and Activities
  • Tyra Biosciences, Inc.
    Professional Services and Activities
  • Wolters Kluwer
    Intellectual Property Rights

If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.

The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.

This page and data include information for a specific MSK annual disclosure period (January 1, 2023 through disclosure submission in spring 2024). This data reflects interests that may or may not still exist. This data is updated annually.

Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].


View all disclosures

Related topics: